{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T14:13:44Z","timestamp":1765808024486,"version":"3.45.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000838","name":"University of Sussex","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000838","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000277","name":"Department for Environment, Food and Rural Affairs, UK Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000277","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Western Pacific"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.lanwpc.2022.100454","type":"journal-article","created":{"date-parts":[[2022,4,10]],"date-time":"2022-04-10T23:28:58Z","timestamp":1649633338000},"page":"100454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Can ivermectin mass drug administrations to control scabies also reduce skin and soft tissue infections? Hospitalizations and primary care presentations lower after a large-scale trial in Fiji"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5951-6608","authenticated-orcid":false,"given":"Jo","family":"Middleton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanwpc.2022.100454_bib0001","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009661","article-title":"A framework for scabies control","volume":"15","author":"Engelman","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lanwpc.2022.100454_bib0002","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S1473-3099(15)00132-2","article-title":"Prevalence of scabies and impetigo worldwide: a systematic review","volume":"15","author":"Romani","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanwpc.2022.100454_bib0003","first-page":"286","article-title":"Scabies increased the risk of chronic kidney disease: a 5-year follow-up study","volume":"28","author":"Chung","year":"2014","journal-title":"JEADV"},{"key":"10.1016\/j.lanwpc.2022.100454_bib0004","article-title":"Prevention of bacterial complications of scabies using mass drug administration, a population-based, before-after trial in Fiji, 2018\u20132020","volume":"22","author":"Thean","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.lanwpc.2022.100454_bib0005","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S1473-3099(18)30558-9","article-title":"Scabies control the forgotten role of personal hygiene \u2013 authors reply","volume":"18","author":"Middleton","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanwpc.2022.100454_bib0006","doi-asserted-by":"crossref","first-page":"e1755","DOI":"10.1371\/journal.pntd.0001755","article-title":"Neglected tropical diseases of Oceania: review of their prevalence, distribution, and opportunities for control","volume":"7","author":"Kline","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lanwpc.2022.100454_bib0007","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1007\/s11625-020-00805-x","article-title":"Rationale, experience and ethical considerations underpinning integrated actions to further global goals for health and land biodiversity in Papua New Guinea","volume":"15","author":"Middleton","year":"2020","journal-title":"Sustain Sci"},{"key":"10.1016\/j.lanwpc.2022.100454_bib0008","article-title":"Scabies and impetigo in Samoa: a school-based clinical and molecular epidemiological study","volume":"6","author":"Taiaroa","year":"2021","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.lanwpc.2022.100454_bib0009","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0001-706X(99)00087-X","article-title":"Treatment with ivermectin reduces the high prevlance of scabies in a village in Papua New Guinea","volume":"75","author":"Bockarie","year":"2000","journal-title":"Acta Trop"},{"key":"10.1016\/j.lanwpc.2022.100454_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004246","article-title":"Long term control of scabies fifteen years after an intensive treatment programme","volume":"9","author":"Marks","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lanwpc.2022.100454_bib0011","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/ijd.12353","article-title":"Scabies community prevalence and mass drug administration in two Fijian villages","volume":"53","author":"Haar","year":"2014","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.lanwpc.2022.100454_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004151","article-title":"Impact of an Ivermectin mass drug administration on scabies prevalence in a remote Australian aboriginal community","volume":"9","author":"Kearns","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lanwpc.2022.100454_bib0013","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/cid\/ciz444","article-title":"Prevalence of scabies and impetigo 3 years after mass drug administration with ivermectin and azithromycin","volume":"70","author":"Marks","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanwpc.2022.100454_bib0014","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1500987","article-title":"Mass drug administration for scabies control in a population with endemic disease","volume":"373","author":"Romani","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanwpc.2022.100454_bib0015","doi-asserted-by":"crossref","first-page":"28S","DOI":"10.3855\/jidc.11701","article-title":"Stopping the itch\u201d: mass drug administration for scabies outbreak control covered for over nine million people in Ethiopia","volume":"14","author":"Enbiale","year":"2020","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.lanwpc.2022.100454_bib0016","series-title":"In: International Alliance for the Control of Scabies Annual Scientific Meeting","article-title":"The secondary impact of ivermectin MDA for the control of onchocerciasis on the prevalence of scabies in the Amhara region of northern Ethiopia","author":"Yirgu","year":"2021"}],"container-title":["The Lancet Regional Health - Western Pacific"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606522000694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606522000694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:38:07Z","timestamp":1763001487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666606522000694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":16,"alternative-id":["S2666606522000694"],"URL":"https:\/\/doi.org\/10.1016\/j.lanwpc.2022.100454","relation":{},"ISSN":["2666-6065"],"issn-type":[{"type":"print","value":"2666-6065"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can ivermectin mass drug administrations to control scabies also reduce skin and soft tissue infections? Hospitalizations and primary care presentations lower after a large-scale trial in Fiji","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Western Pacific","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanwpc.2022.100454","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.lanwpc.2022.100433","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100454"}}